Navigation Links
Addiction in Biological Technology

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

... the use of CPP-109 for the treatment of cocaine addiction and our proof-of-concept study evaluating the use ... McEnany concluded, "Catalyst, along with leading addiction clinicians across the U.S., continues to seek ... under the NIH umbrella, for future vigabatrin addiction trials and to provide a portion of the required ...

Matt Bars, a Global Expert in Smoking Cessation, Joins Next Safety as Chairman

... and is a member of the American Academy of addiction Psychiatry. He is a consultant and key ... management, and administration of nicotine addiction services since 1980. Mr. Bars is a ... Service). "I have worked against nicotine addiction for almost 30 years and I am excited to be ...

Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results

... this trial, having enrolled 186 subjects at 11 addiction centers around the United States. Initial ... CPP-109 for the treatment of methamphetamine addiction using a trial protocol that is almost identical ... of prescription drugs for the treatment of addiction and obsessive-compulsive disorders. The Company ...

Addiction Treatment Finds Success Treating Brain Deficiencies through the Belly

... Arche Wellness, a licensed addiction treatment program near Pittsburgh PA, has found success treating addiction by focusing on patients' malfunctioning ... and amino acids for those struggling with addiction to alcohol, heroin, methadone, buprenorphine and ...

Laser Therapy Gives Smokers Hope for Successful New Year's Resolution

... achieve their goal of breaking their smoking addiction forever," states David Jackson, CEO of Achieve ... Mr. Jackson personally overcame his nicotine addiction after more than 15 years of smoking a pack a day. ... "This allows our clients to overcome their body's addiction faster and without side-effects." For ...

Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference

... develops and commercializes prescription drugs for the treatment of drug addiction and obsessive compulsive disorders, today announced that Patrick J. ... and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from ...

Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering

... develops and commercializes prescription drugs for the treatment of drug addiction and obsessive compulsive disorders, today announced that it has entered ... and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from ...

Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement

... develops and commercializes prescription drugs for the treatment of drug addiction and obsessive compulsive disorders, today announced the filing of a shelf ... and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from ...

deCODE genetics Announces First Quarter 2008 Financial Results

... genetic factors involved in prostate cancer, breast cancer, nicotine addiction and lung cancer, osteoporosis, intracranial and abdominal aortic ... latter phases of development of DG041. Target Discovery -- Nicotine addiction and lung cancer. In April, deCODE scientists reported a clear link ...

Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions

... hospital and outpatient practice which provides mental health and addiction services to 10,000 persons of all ages annually, will transition clinical ... years ago, Manatee Glens is a not-for-profit provider of mental health and addiction inpatient, detox, residential psychiatric and treatment and counseling ...

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

... extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in ...

AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction

... antagonist AEZS-123 reduced body weight gain and fat accumulation in an animal model of diet-induced obesity. About the Food and Alcohol addiction Market There is no safe and effective appetite suppressant currently on the market. It is estimated that between 34 million and 61 million ...

Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice

... Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive-compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for nine patents in ...

Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes

... extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in ...

Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events

... extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in ...

Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

... or next day hangover effects that are commonly associated with other sleep medications. ITI-007 is expected to have a strong safety profile with no addiction liability. This compound is being evaluated for the treatment of sleep disorders in various patient populations with sleep maintenance problems and ...

Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation

... of unanticipated events. About Rock Creek Pharmaceuticals Rock Creek Pharmaceuticals develops pharmaceutical products for treatment of addiction and other neurological disorders. The company supports third-party academic, educational and therapeutic advances in both these areas of research. ...

USC researchers derive first embryonic stem cells from rats

... ES cells will greatly facilitate the creation of rat models for the study of different human diseases, such as cancer, diabetes, high blood pressure, addiction and autoimmune diseases." Ying, a native of China, notes that this breakthrough research occurred during 2008, the Chinese year of the rat. ...

Top 10 Cognitive Fitness Events of 2008 to be Unveiled at SharpBrains' Webinar

... treatments. 8) August: CogniFit secures $5 million from Milk Capital. 9) September: The Paul Wellstone and Pete Domenici Mental Health Parity and addiction Equity Act of 2008 is signed into law. 10) October: Allstate launches a large-scale research project to measure the impact of Posit Science InSight ...

A Better Tomorrow Treatment Center Inc., Forterus Inc.'s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior

... nation to offer GenRecovery, a DNA-customized program for individuals with a genetic predisposition for addictive behavior. "As one of the leading addiction treatment centers in California, A Better Tomorrow is constantly striving to improve its success rate with addiction treatment. And one way to do ...

Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results

... Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for nine patents and ...

A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease

... complex health challenges. Not only have we made a convincing link between a single SNP and a behavioral disorder -- greater smoking quantity and addiction to nicotine -- but also demonstrated how this risk factor translates into risk of lung cancer and PAD. This is an important advance that we will use ...

Misperceptions About Smoking Cessation Aids May Hinder Smokers From Using Effective Treatment for Quitting

... and support services designed specifically to help smokers and non-smokers understand and address the two components to smoking cessation: nicotine addiction and habit change. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R), NicoDerm(R) CQ and Commit(R) as ...

Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder

... extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Alkermes is headquartered in Cambridge, Massachusetts, with research and manufacturing facilities in Massachusetts and Ohio. For more ...

Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics

... medical laboratory specializing in advanced, state-of-the-art clinical quantitative urine drug testing and monitoring for Pain Management, addiction Medicine, Primary Care, Mental Health and Well-Being, Behavioral Health, and Hospital Systems. For more information, please visit ...

PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities

... professional (HCP administered) or self-administered. His expertise includes a broad range of therapeutic areas, including oncology, HIV/AIDS, addiction medicine, hormone replacement therapy, gastroenterology, and urology. Mr. Stevens holds a Bachelor's degree from Northeastern University, an MBA from ...

AIDS and tobacco are worldwide killers: Is bioscience doing enough to stop them?

... Educating the worlds smokers about the dangers of tobacco use is one long-term strategy, Loftus said, but an effective drug to break their addiction would accomplish even more. Its tempting for researchers to focus on the North American and European markets because thats where the money can be ...

UW-Milwaukee Chancellor Santiago determined to build on research base

... six years, and increasing the amount of interdisciplinary research. As examples of high-growth programs, Santiago cited campus research in water, addiction and behaviors, mathematics, medicinal chemistry and Internet-based maintenance solutions for manufacturing. Each program has grown with relatively ...

Are guest worker programs causing backlash amid IT downsizing?

... American worker replacement program in disguise. All American workers in all job categories and pay scales can be replaced by this program. The addiction U.S. employers have for exploiting non-immigrant guest worker visa programs and sending jobs overseas has caused significant losses in wealth and ...

Bush praises Johnson Controls battery tech in Milwaukee visit

... but rather than concentrate on traditional energy resources, his remarks were directed toward new methods of treating what he called the nation's addiction to foreign oil. In an address before employees at Johnson Controls, a Milwaukee-based automotive battery manufacturer that is developing a new ...

Doyle, Kind call for higher renewable fuel standard

... be comprised of renewable fuels like ethanol by 2015. "Increasing the federal renewable fuel standard would be a major step toward kicking our addiction to foreign oil," Doyle said. "We have the resources and the ingenuity to get this done." The standard, which some credit with accelerating growth ...

Wisconsin will have plenty of competition in building the energy future

... With new technology, and a commitment to renewable fuels, Wisconsin can lead the way - reducing global warming and helping this nation kick its addiction to foreign oil. The Office on Energy Independence will coordinate the state's efforts to grow Wisconsin's bio and renewable economies and advise ...
Other Contents
(Date:7/31/2014)... New research, supported by the National Science Foundation ... permafrost uniformly accelerates atmospheric warming, indicating instead that ... they emit into the atmosphere. , The ... Nature , focuses on thermokarst lakes, which occur ... fill with melted fresh water, converting what was ...
(Date:7/31/2014)... NCT00518336) shows the sustained efficacy, immunogenicity and ... vaccine Cervarix. Women vaccinated with the HPV-16/18 ... nine years, and vaccine efficacy (VE) against ... longest follow-up report for a licensed HPV ... full paper. , HPV and vaccination ...
(Date:7/31/2014)... An experimental vaccine protected 100 percent of animal models ... difficile , which causes an intestinal disease that kills ... of print in Infection and Immunity . ... and non-human primates against the purified toxins produced by ... orogastric spore infection, a laboratory model that mimics the ...
Breaking Biology News(10 mins):Certain Arctic lakes store more greenhouse gases than they release 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3C. difficile vaccine proves safe, 100 percent effective in animal models 2
(Date:8/1/2014)... 2014 Stress management can be difficult in ... of concentration and diminish rest and leisure time, stress can ... critical to find a way to manage stress in order ... , “Having a good sense of work-life balance is the ... founding clinician of SF Custom Chiropractic. “Stress, left unchecked, ...
(Date:7/31/2014)... Just in time for Washington’s unusually ... is featuring new summertime drink specials on their famed ... locations throughout the season. , A longtime ... customer-nominated Seattle’s best happy hour is well-known for its ... Union location’s 25th anniversary this summer, Duke is now ...
(Date:7/31/2014)... have asthma, you may have an asthma action plan with ... to changes and understand when symptoms are getting worse and ... doing well, yellow means your asthma has worsened and action ... guidelines are now available to help your allergist steer you ... from the red zone. , "Management of acute loss of ...
(Date:7/31/2014)... The 2013 PolyU TSI hit a record ... in 2012. The index measures inbound tourists’ satisfaction ... into an overall index. The 2013 index indicates ... Hong Kong over time. , The index shows ... in Hong Kong are attractions (79.27) and transportation ...
(Date:7/31/2014)... Dayton, Ohio (PRWEB) July 31, 2014 ... year at 9 a.m. on Monday, September 15, with ... United Methodist Church, 3440 Shroyer Rd., Kettering, OH. ... and Counseling in the Emma Toussant Chair will speak ... Ministry." , Dr. Justes’ teaching and research interests include ...
Breaking Medicine News(10 mins):Health News:SF Custom Chiropractic Celebrates National Relaxation Day and the Benefits of Massage Therapy for the Month of August 2Health News:Seattle Seafood Restaurant Lake Union Duke's Chowder House Celebrating its 25th Anniversary, Still a Best Outdoor Deck Spot to Sip Up Cocktails in Record-Breaking Heat. 2Health News:Seattle Seafood Restaurant Lake Union Duke's Chowder House Celebrating its 25th Anniversary, Still a Best Outdoor Deck Spot to Sip Up Cocktails in Record-Breaking Heat. 3Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 2Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 3Health News:United Theological Seminary to Open 144th Year 2
Other TagsOther Tags